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Intestinal diamine oxidase (DAO) acts as a protective barrier against exogenous histamine. A 23 
deficit of DAO activity can lead to the appearance of histamine intolerance, a clinical condition 24 
that may be treated by a low-histamine diet and oral DAO supplementation to enhance 25 
intestinal histamine degradation. As sources of DAO, porcine kidneys and certain legume 26 
seedlings are suitable components for the formulation of a DAO supplement. The aim of this 27 
work was to develop a rapid and reliable methodology for the in vitro determination of DAO 28 
activity in food matrices based on an enzymatic assay coupled to UHPLC-FL. The proposed 29 
method showed a satisfactory linearity and sensitivity and provided a relative standard 30 
deviation lower than 3%, guaranteeing method precision, and a mean recovery greater than 31 
99% both for lyophilized pea sprouts and porcine kidney protein extracts. A high specificity is 32 
a key attribute of this method due to the use of histamine as the reaction substrate and the 33 
direct quantification of its degradation. Moreover, the lack of interference of catalase and 34 
hydrogen peroxide is another advantage in comparison with previously published methods. 35 
Lyophilized pea sprouts showed the greatest histamine-degrading activity (0.40 ±0.01 36 
mU/mg), followed by porcine kidney protein extracts (0.23 ±0.01 mU/mg) and commercial 37 
DAO supplements (0.09 ±0.06 mU/mg). This technique could be used as a tool to validate the 38 
DAO activity of food matrices of potential interest for the treatment of histamine intolerance. 39 
 40 
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1. Introduction 44 
The enzyme with histamine-degrading capacity, discovered in 1929 by Charles H. Best in 45 
autolyzing lung tissues, was first known as histaminase [1]. After subsequent studies revealed 46 
its ability to deaminate other diamines, such as putrescine and cadaverine, the enzyme was 47 
renamed diamine oxidase (DAO) [2,3]. DAO (EC 1.4.3.22), which belongs to the category of 48 
copper-containing amine oxidases, is a homodimeric and ubiquitous enzyme found in 49 
microorganisms, plants and animals, generally in the range of 140 to 200 kDa [4-8]. In 50 
particular, DAO catalyzes the oxidative deamination of the primary amino group of histamine 51 
to imidazole acetaldehyde, consuming dioxygen with the concomitant release of 52 
stoichiometric amounts of ammonia and hydrogen peroxide (Figure 1) [9, 10]. 53 
In humans, DAO is mainly located in the intestines, placenta and kidneys [6,11]. Intestinal 54 
DAO acts as a protective barrier against exogenous histamine, especially of food origin [12-55 
14]. A deficiency of DAO enzyme may thus lead to excess the normal plasmatic levels of 56 
histamine (0.3 - 1.0 ng/mL) and the subsequent appearance of histamine intolerance 57 
symptoms [15, 16]. Due to the diverse effects and functions of histamine in multiple organs 58 
and systems of the body, histamine intolerance is characterized by a variety of complaints, 59 
including gastrointestinal (abdominal pain, diarrhea or vomiting), dermatological (urticaria, 60 
dermatitis or pruritus), respiratory (rhinitis, nasal congestion or asthma), cardiovascular 61 
(hypotonia or arrhythmias) or neurological (headaches) [14-17]. The most frequently used 62 
treatment for histamine intolerance consists of following a low-histamine diet [15, 18]. Only 63 
foods with histamine levels below detectable limits can be considered safe for histamine-64 
intolerant patients and unfortunately for this population, histamine is widespread among all 65 
food categories in highly variable concentrations [19, 20]. In this context, considering that 66 
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DAO is the key enzyme in the breakdown of dietary histamine at the intestinal level, orally 67 
administered DAO supplements have been proposed as a strategy to enhance histamine 68 
degradation and improve the quality of life of intolerant individuals undergoing those dietary 69 
restrictions [21, 22]. As sources of DAO, porcine kidneys and certain legume seedlings are 70 
suitable components of such an enzymatic supplement [21, 23].  71 
A wide range of methods to detect in vitro DAO activity are described in the literature. With 72 
the aim of measuring the rate of substrate degradation or the generation of by-products of 73 
this enzymatic reaction, most methods are based on the detection of hydrogen peroxide, 74 
aldehyde or dioxygen by spectrophotometric [13, 21, 24, 25], fluorometric [26], polarographic 75 
[27, 28] or amperometric [29, 30] techniques. Radioimmunoassay techniques have also been 76 
extensively described, consisting of the radioactive labeling of the substrate and the 77 
scintillation counting of its consumption [3, 11, 31]. Although chromatographic analytical 78 
procedures are widely used, this approach has only been applied to measure histamine or 79 
other biogenic amine degradation capacity in microbial starter cultures involved in food 80 
fermenting processes [10, 32, 33]. Despite some of these methods may be advantageous in 81 
terms of rapidity or automation, they generally have a limited sensitivity, require a laborious 82 
experimental set-up or entail a high cost in the correct storage and handling of radioactive 83 
waste. Moreover, in those methods in which the DAO activity is estimated through the 84 
determination of hydrogen peroxide or dioxygen, the action of other enzymes, such as 85 
catalase, may interfere by H2O2 consuming or O2 releasing [34, 35]. Additionally, the most 86 
extensively used reaction substrates in the methods reported so far are putrescine and 87 
cadaverine, which have different affinity or kinetic parameters to histamine [36, 37].  88 
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Therefore, the aim of this work was to develop a reliable, rapid and highly sensitive 89 
methodology for the determination of in vitro DAO activity of several matrices using 90 
histamine as the substrate and based on the direct quantification of its degradation during 91 
the reaction process. Specifically, an enzymatic assay coupled to an ultra-high performance 92 
liquid chromatography and fluorimetric (UHPLC-FL) detection method was proposed, 93 
validated and tested for applicability in porcine kidney protein extracts, legume sprouts and 94 
commercialized DAO supplements. 95 
 96 
2. Material and methods 97 
2.1. Reagents and chemicals 98 
Histamine dihydrochloride, purified DAO from porcine kidney and catalase from bovine liver 99 
were purchased from Sigma-Aldrich (St. Louis, MO, USA). UHPLC-grade methanol and 100 
acetonitrile, hydrochloric acid 0.1M, perchloric acid 70%, sodium di-hydrogen phosphate 101 
anhydrous and di-sodium hydrogen phosphate anhydrous were obtained from PanReac 102 
Química (Castellar del Vallès, Spain). Acetic acid, boric acid, 1-octanesulfonic acid sodium salt, 103 
ammonium formate, phthaldialdehyde (OPA) and brij® L23 solution were acquired from 104 
Sigma-Aldrich (St. Louis, MO, USA); and formic acid, sodium acetate anhydrous, potassium 105 
hydroxide and 2-mercaptoethanol from Merck (Darmstadt, Germany). A LaboStar System 106 
from Evoqua Water Technologies (Warrendale, PA, USA) was used to produce ultrapure water 107 
(18.2 MΩcm). 108 
 109 
2.2. Samples 110 
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For the analytical method development and validation, porcine kidney protein extracts and 111 
lyophilized pea sprouts (Pisum sativum) were used. Porcine kidney extracts were provided by 112 
a biotechnology company specialized in the extraction of biomolecules from animal tissues. 113 
These extracts consisted of a homogenate powder obtained by an acetonic extraction 114 
followed by a drying process. Porcine kidney extracts consisted of 84% of protein, estimated 115 
by applying the nitrogen-to-protein conversion factor (6.25) to the total nitrogen determined 116 
following the Kjeldahl method (2200 Kjeltec® Auto Distillation Unit, Foss Iberia S.A.U., 117 
Barcelona, Spain). Etiolated pea sprouts were obtained in our laboratory through the 118 
germination of peas at 27ºC and 70% HR. After the sprouts were freeze-dried (Cryodos-50, 119 
Telstar, Terrassa, Spain), a lyophilized extract consisting of 39% of protein was obtained. 120 
Samples were kept under refrigeration (4-8 °C) until analysis. 121 
The applicability of the method was assayed with 13 different production batches of porcine 122 
kidney protein extract, 7 batches of lyophilized pea sprouts and 6 commercialized DAO 123 
supplements available in the market. These dietary supplements were in the form of gastro-124 
resistant coated capsules or tablets, all of them containing 4.2 mg of porcine kidney protein 125 
extract.  126 
 127 
2.3. In vitro determination of DAO activity 128 
The capacity of the DAO enzyme to degrade histamine in a working solution with a defined 129 
initial concentration of histamine was tested under controlled optimal conditions (37°C, pH 130 
7.2). The subsequent analysis of degraded histamine during the reaction time was performed 131 
by UHPLC-FL. Specific DAO activity is expressed in mU/mg, referring to the amount of 132 
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histamine that is degraded by a mg of sample per minute (nmol of degraded histamine per 133 
minute/mg of sample). 134 
 135 
2.3.1. Enzymatic assay 136 
Figure 2 illustrates in a schematic manner the experimental procedure of the enzymatic assay 137 
for the in vitro determination of DAO activity. In detail, 1 to 20 mg of porcine kidney protein 138 
extract, lyophilized pea sprouts or the content of one tablet or capsule of dietary supplement 139 
were thoroughly homogenised in 20 mL of 0.05M phosphate buffer solution (pH 7.2) and 140 
placed in a shaker incubator (Ivymen® 100-D, JP SELECTA S.A., Abrera, Spain) for at least 30 141 
min (37°C, 200 rpm). The addition of a histamine standard solution to reach an initial 142 
concentration of 45 µM in the homogenized sample marked the start of the enzymatic 143 
reaction. The enzyme in contact with its substrate was kept in constant incubation and 500 144 
µL aliquots were progressively extracted at different sampling times (t=0, 1, 2, 4 and 6 h). To 145 
stop the enzymatic reaction, 15 µL of 2N perchloric acid solution was added to the extracted 146 
aliquot, vigorously mixed with a vortex mixer and centrifuged (4°C, 5 min, 15000 rpm). The 147 
supernatant was filtered through a 0.22 µm GHP filter and stored at 4°C until UHPLC analysis. 148 
Each sample was analyzed in duplicate and a positive control was performed with 1 mg of 149 
purified DAO.  150 
To assay the potential interference effect of catalase on the DAO activity determination, 151 
porcine kidney protein extract was assayed with the addition of catalase enzyme at two 152 
different concentrations (100 and 500 U/mL) using the same experimental procedure. 153 
 154 
2.3.2. UHPLC-FL analysis 155 
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Chromatographic separation was performed using a UHPLC-FL system consisting of a Waters 156 
Acquity™ Ultra Performance Liquid Chromatography apparatus, which comprised a 157 
quaternary pump, an auto-sampler and a fluorescence detector, and a post-column reagent 158 
manager connected to a zero dead volume union between the column outlet and the 159 
detector. Data acquisition was performed using the EmpowerTM 3 software (Waters Corp., 160 
Milford, MA, USA). 161 
The chromatographic determination of histamine was performed by ion-pair reverse-phase 162 
UHPLC coupled with post-column online derivatization with OPA and fluorescence detection. 163 
Elution time was 7 min. Chromatographic conditions were as previously described by Latorre-164 
Moratalla et al. [38], briefly summarized in Table 1.  165 
 166 
2.4. Statistical analysis 167 
The software package IBM SPSS Statistics (IBM Corporation, Armonk, NY, USA) for Windows 168 
(version 22) was used for the statistical analysis of data. The reliability of the method was 169 
tested by means of analysis of variance for linear regression and the data sets were compared 170 
using the Student’s t-test. Cochran’s C test was used to assess the homogeneity of variances. 171 
 172 
3. Results and discussion 173 
The method developed in this work is based on the direct addition of a defined amount of 174 
histamine to a food matrix homogenized in an aqueous solution. During the incubation period 175 
of the mixture, the DAO enzyme potentially present in the sample progressively degrades the 176 
substrate. DAO activity was determined by comparing the absolute amount of histamine 177 
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degraded during the reaction time with the initial substrate concentration. The absence of 178 
histamine degradation when assaying the same amount of substrate but lacking the DAO 179 
enzyme or samples as a negative control proved that the degradation of histamine in the 180 
proposed method is exclusively mediated by the enzyme. 181 
The UHPLC-FL method allowed us to unequivocally determine the remaining histamine in the 182 
samples with a chromatographic elution time of 7 minutes and without the need for tedious 183 
pre-column derivatization procedures. The selected substrate concentration was 45 µM of 184 
histamine, in accordance with published kinetic data for DAO activity on this specific amine, 185 
to ensure optimal performance of the enzymatic reaction [9, 39, 40]. The degradation of 186 
histamine was monitored for 48 hours to study the enzymatic reaction. A linear histamine 187 
degradation rate was observed in the first 6 hours of the assay (r > 0.9990) for both porcine 188 
and legume matrices. 189 
 190 
3.1. Method reliability  191 
The linearity of the method was assessed by performing in triplicate seven determinations of 192 
different enzymatic activities using purified DAO and verified by analysis of the variance of 193 
the regression. A correlation coefficient of r=0.9998 and a coefficient of determination (r2) 194 
higher than 99% were obtained (p<0.001), demonstrating the satisfactory performance of the 195 
method within the DAO activity range of 0.7 to 4.5 mU. Regarding method sensitivity, the 196 
limit of detection (LOD) and the limit of quantification (LOQ) were estimated using a 197 
regression curve with low DAO activity values and considering the mean response of a blank 198 
plus three or ten times the standard deviation of the blank, respectively [41]. Specifically, the 199 
value obtained for LOD was 0.025 mU and for the LOQ it was 0.038 mU. 200 
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The precision and recovery of the proposed method for routine analysis of DAO activity were 201 
assessed with different batches of porcine kidney protein extract and lyophilized pea sprouts. 202 
The precision was evaluated by performing 7 independent determinations of DAO activity for 203 
each food matrix (Table 2). The relative standard deviation was in both cases lower than 3 %, 204 
showing a satisfactory level of precision. The Horwitz equation for intra-laboratory studies 205 
confirmed the acceptability of this precision data [42]. Recovery was evaluated by performing 206 
7 independent determinations of porcine kidney extract and lyophilized pea sprouts, 207 
considering 3 addition levels with purified DAO (Table 2). The recovery values obtained for 208 
the three levels of addition were satisfactory and no statistical differences from the 209 
theoretical value 100% were found (p> 0.05) [42]. The variance of the recovery values was not 210 
dependent on the content of the analyte according to Cochran’s C test (p>0.05). 211 
Among the range of methodologies described in the literature that challenge the 212 
determination of DAO activity, the majority are based on the measurement of the liberation 213 
of hydrogen peroxide or the consumption of oxygen occurring along the oxidative 214 
deamination reaction [13, 21, 24-30]. Those largely used approaches face an important 215 
drawback, as the presence of hydrogen peroxide and dioxygen may be markedly influenced 216 
by the concomitant presence of other enzymatic capacities in certain complex biological 217 
matrices [34, 35]. This is the case of catalase, an enzyme commonly found in plant and animal 218 
tissues, which can lead to the underestimation of DAO activity by consuming H2O2 and 219 
releasing O2 [34, 35]. Therefore, the frequent occurrence of catalase in DAO-positive matrices 220 
makes those techniques unadvisable due to major interference effect. In this sense, 221 
Ahmadifar et al. [35] have recently proposed a zymographic approach consisting in an 222 
electrophoretic separation of DAO enzyme followed by its densiometric image analysis 223 
capable to evaluate the DAO activity of a sample in the presence of interfering catalase. 224 
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Concurrently, all those methods consisting in the monitoring of hydrogen peroxide release 225 
through a coupled reaction with peroxidase entail further complexities, such as a potential 226 
partial substrate inhibition produced by excess of hydrogen peroxide [43]. In general, coupled 227 
peroxidase assays may be targeted as unreliable when working with purified DAO enzyme 228 
and totally unadvisable when studying non-purified complex samples due to the presence of 229 
peroxidase inhibitors or other enzymatic activities [34, 44]. In fact, Calinescu et al. [34] 230 
evaluated the DAO capacity of formulation containing a vegetal extract with the presence of 231 
catalase, using both a peroxidase coupled assay and an alternative assay non-related to 232 
peroxidase enzyme. In this context, the authors described the unsuitability of the peroxidase 233 
coupled assay due to the diminution of released H2O2 by catalase enzyme, emphasising the 234 
need to seek for enzymatic tests not affected by the presence of catalase [34]. In this sense, 235 
methods based in the direct measurement of the degradation of the amine substrate, 236 
hitherto scarcely described in the literature, may overcome this limitation. In the proposed 237 
method, DAO activity of the porcine kidney extract did not significantly differ (p>0.05) when 238 
was determined with or without the addition of catalase, and independently of the 239 
concentration of this enzyme added to the sample. Therefore, the proposed method herein 240 
is not influenced by the presence of catalase present in the analyzed food matrices, since it is 241 
based in the direct determination of histamine. 242 
Although the largely used spectrophotometric techniques seem to be sensitive enough for 243 
the analysis of samples with an elevated degree of purification, there is a lack of a reliable 244 
and sensitive methods that allow to determine DAO activity in complex biological or food 245 
matrices, which will not only contain several potential interferences but will also show 246 
relatively low enzymatic rate. In this case, radiochemical detection techniques based on the 247 
use of C14-labelled putrescine becomes the preferred approach [44]. However, while a high 248 
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sensitivity may be attributed to the latter, serious concerns related to the hazardous potential 249 
in the handling of radioactive material and the high cost and unsuitability of its storage need 250 
to be considered. The proposed method shows the advantages of sensitivity, reproducibility 251 
and automatization of an UHPLC approach while avoiding user-related hazardous potential 252 
and becomes a suitable approach to analyze DAO activity in complex non-purified matrices. 253 
 254 
3.2. Suitability of the method for the determination of DAO activity in porcine kidney 255 
protein extracts, lyophilized pea sprouts and DAO supplements 256 
The applicability of the developed method was tested by analyzing several production 257 
batches of porcine kidney protein extract and lyophilized pea sprouts. Additionally, the 258 
enzymatic capacity of porcine kidney extract in DAO supplements available in the market was 259 
studied. All analyzed products showed in vitro histamine-degrading capacity (Figure 3). 260 
Lyophilized pea sprouts were the most effective, with a mean enzymatic activity of 0.40 261 
(±0.01) mU/mg, compared to 0.23 (±0.01) mU/mg for porcine kidney protein extracts. It is 262 
worth highlighting that the DAO activity of both products showed minimal variation among 263 
different production batches. These results are in good agreement with previously published 264 
data indicating a higher catalytic turnover rate for plant- than animal-derived DAO [5, 23, 37]. 265 
The amine-degrading capacity described in the literature for these food matrices is highly 266 
variable, with values ranging from 0.1 to 500 mU/mg. Different behavior toward the same 267 
amino substrates has been reported for DAO enzymes depending on whether they are of 268 
animal or plant origin [37]. This heterogeneity could also be explained by differences in 269 
methodology between studies, as a range of detection techniques and substrates have been 270 
used. Thus, Kivirand et al. [7] suggested that the substrate specificity data available for DAO 271 
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varied according to the experimental method and recognized an important difficulty to find 272 
comparable data due to the evidenced dispersion of methodological procedures. Concretely, 273 
the wide range of used substrates (i.e. putrescine, cadaverine, agmatine, histamine, 274 
spermidine and spermine) may easily lead to differences in the reported enzymatic activities, 275 
as the affinity of DAO for each substrate varies [36, 37]. Due to the evidenced differences in 276 
kinetic parameters depending on the amino substrates, histamine is the optimal substrate in 277 
order to have an available methodology to determine the enzymatic activity of potential new 278 
sources of DAO, considering the degradation of this target substrate and no other amines. 279 
Porcine kidneys and pea seedlings are the main sources of DAO according to the literature 280 
[21, 23], but it can also be found in other food products, such as certain legumes (Cicer 281 
arientum, Lathyrus sativus, Lens esculenta), barley (Hordeum vulgare), maize (Zea mays) and 282 
tea (Thea sinensis) [21, 23, 36]. The method proposed here could be applied to validate the 283 
in vitro enzymatic capacity of these food matrices and to screen for new potential sources of 284 
DAO.  285 
The DAO activity of the six commercial DAO supplements ranged widely from 0.04 to 0.20 286 
mU/mg, despite all being formulated with the same amount of porcine kidney extract (4.2 287 
mg) (Figure 3). In comparison with the raw porcine extract (0.23 ± 0.01 mU/mg), a markedly 288 
lower DAO activity was generally observed in these supplements. The application of different 289 
galenic formulation processes may influence the enzymatic capacity of the kidney extract, 290 
which would explain both the variability and loss of activity of the DAO supplements. Further 291 
studies are required to understand how different technological parameters linked to the 292 
manufacturing process of these supplements influence the enzymatic activity. The variable 293 
activity of commercial DAO supplements could help explain the different efficacy rates 294 
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reported by clinical studies evaluating the use of exogenous DAO to treat symptoms 295 
associated with histamine intolerance [22, 45-47]. 296 
Few studies have estimated the intestinal DAO activity in a healthy population. An enzymatic 297 
activity of 0.001 - 0.03 mU/mg has been reported in the intestinal mucosa, with higher values 298 
given for intestinal protein (0.2 - 0.33 mU/mg) [31, 48-50]. As indicated by the manufacturers, 299 
the usual posology of DAO supplements is 1 capsule before each meal, which provides an 300 
enzymatic activity in the range of 0.17 to 0.84 mU, depending on the product. In view of these 301 
results, more accurate studies are needed in order to establish the effective dosage of DAO 302 
that can provide a complementary intestinal protective barrier for histamine-intolerant 303 
individuals. 304 
 305 
4. Conclusion 306 
The proposed method, consisting of an enzymatic assay coupled to a UHPLC-FL technique, 307 
allowed the in vitro determination of DAO activity in food matrices using histamine as the 308 
reaction substrate. This method provided satisfactory experimental performance in terms of 309 
linearity, sensitivity, precision and recovery, and its suitability was tested on different food 310 
matrices reported as sources of DAO. The DAO activity of lyophilized pea seedlings was nearly 311 
two-fold higher than that of porcine kidney protein extracts. The histamine-degrading 312 
capacity of the six DAO supplements available in the market was variable and lower compared 313 
to the other analyzed matrices. Due to the growing awareness of histamine intolerance, it is 314 
important to have effective methods for validating the DAO activity of supplements and foods 315 
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Figure captions 472 
Fig. 1 Oxidative deamination of histamine by DAO 473 
Fig. 2 Schematic experimental procedure of the enzymatic assay for the in vitro 474 
determination of DAO activity 475 
Fig. 3 In vitro DAO activity of several production batches of porcine kidney protein extract, 476 
lyophilized pea sprouts and different commercial DAO supplements 477 
 478 
Table 1. Chromatographic conditions for the UHPLC-FL determination of histamine 479 
Stationary phase   
Column Acquity UPLC™ BEH C18 column (1.7 μm, 2.1 mm x 50 mm)  
Column temperature 42 °C  
Mobile phase  
Eluent A H2O solution with 0.1 M sodium acetate and 10 mM sodium 
octanesulphonate (adjusted to pH 4.8 with acetic acid) 
Eluent B H2O solution with 0.2 M sodium acetate and 10 mM sodium 
octanesulphonate (adjusted to pH 4.5 with acetic acid) : 
Acetonitrile (6.6:3.4) 
Linear gradient 0 min, 80% A; 2 min, 80% A; 3 min, 60% A; 4 min 50% A; 5 
min, 40% A; 6 min, 20% A; 6.40 min, 80% A; 7 min, 80% A.  
Flow rate 0.8 mL/min 
Injection volume 1 μL  
Fluorescence detection  
Derivatization reagent OPA (0.2 mg/mL), brij®, 2-mercaptoethanol, methanol, 
potassium hydroxide and boric acid 
Excitation and emission 
wavelengths 
340 nm and 445 nm  




Table 2. Precision and recovery results for porcine kidney extracts and lyophilized pea sprouts 481 
 482 
  Precision     Recoveryc 
  RSD (%)a RSDH (%)b   Addition level I Addition level II Addition level III Cochran's test Cexpd 
                
Porcine kidney extract 2.76 3.45-4.60   100.54 (4.98) 102.69 (5.44) 99.14 (2.52) 0.41 
                
Lyophilized pea sprouts 2.80 3.27-4.36  101.28 (0.90) 100.00 (0.76) 100.51 (2.61) 0.05 
                
 483 
a
 Relative standard deviation (RSD) for seven determinations. 484 
b
 Acceptable range for relative standard deviations according to the Horwitz equation for intra-laboratory studies (1/2 - 2/3 of the 485 
interlaboratory study calculate by the formula). 486 
c Mean recovery percentages and standard deviation in parentheses for three addition levels corresponding to enzymatic activities of 0.5, 1.0 487 
and 2.0 mU for porcine kidney extract and 1.0, 2.0 and 4.0 mU for lyophilized pea sprouts. 488 
d















Sample homogenisation in 
a phosphate buffer solution
Start of the enzymatic reaction 
with the addition of histamine
Constant incubation of the 
reaction mixture
Extraction of aliquots at 
different reaction times
UHPLC-FL analysis of 
remaining histamine
Porcine kidney extract
Lyophilised pea sprouts
Commercial DAO supplement
 
 
 
